Particle Therapy 2017

Challenges for new centers

• Increase in number of centres –

Historical niche will not fill to full capacity Common cancer sites will have to be treated

–

• Superior beam but –

level-I clinical evidence is lacking

– – –

Non-randomized comparaBve evidence is scarce

How choosing candidate cancers?

How dealing with cost and reimbursement • This course: overview of clinical data with emphasis on comparaBve assessments